OHSU develops prostate cancer drug

OHSU develops prostate cancer drug

There is a promising development in the fight against prostate cancer.

Researchers at Oregon Health & Science University's Knight Cancer Institute conducted a double blind study, testing a new drug called Enzalutamide.

Half of the 1,700 patients got the real pill. The other half got a placebo. Results were so impressive that researchers stopped the trial and gave the pill to the placebo group, too.

 

Read more at KGW.